Effect of storage time of paraffin sections on the expression of PD-L1 (SP142) in invasive breast cancer

被引：0
|
作者：
Jiankun He
Xinran Wang
Lijing Cai
Zhanli Jia
Chang Liu
Xuemei Sun
Si Wu
Chunyan Ding
Zi Zhang
Yueping Liu
机构：
[1] the Fourth Hospital of Hebei Medical University,Department of Pathology
来源：
Diagnostic Pathology | / 18卷
关键词：
Breast cancer; PD-L1; Immunohistochemistry; Paraffin sections; Storage time;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PD-L1 (SP142) Immunohistochemistry in Clinical Metastatic Breast Carcinomas and its Association with Survival
    Shafi, Saba
    Challa, Bindu
    Parwani, Anil
    Li, Zaibo
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 192 - 194
  • [22] Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
    Vennapusa, Bharathi
    Baker, Brian
    Kowanetz, Marcin
    Boone, Jennifer
    Menzl, Ina
    Bruey, Jean-Marie
    Fine, Gregg
    Mariathasan, Sanjeev
    McCaffery, Ian
    Mocci, Simonetta
    Rost, Sandra
    Smith, Dustin
    Dennis, Eslie
    Tang, Szu-Yu
    Damadzadeh, Bita
    Walker, Espen
    Hegde, Priti S.
    Williams, J. Andrew
    Koeppen, Hartmut
    Boyd, Zachary
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 92 - 100
  • [23] Development of a PD-L1 companion diagnostic IHC assay (SP142) for atezolizumab
    Boyd, Zachary S.
    Smith, Dustin
    Baker, Brian
    Vennapusa, Bharathi
    Koeppen, Hartmut
    Kowanetz, Marcin
    Mariathasan, Sanjeev
    Bruey, Jean-Marie
    Mackey, Howard
    Fine, Gregg
    Mocci, Simonetta
    Hegde, Priti
    Williams, J. Andrew
    McCaffery, Ian
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [24] y Frequency, characteristics and prognostic factors of PD-L1+triple negative breast cancer using the PD-L1 SP142 companion assay
    Carter, Jodi M.
    Polley, Mei-Yin C.
    Sinnwell, Jason P.
    Leon-Ferre, Roberto A.
    Couch, Fergus J.
    Kalari, Krishna R.
    Boughey, Judy C.
    Liu, Minetta C.
    Visscher, Daniel W.
    Goetz, Matthew P.
    CANCER RESEARCH, 2020, 80 (04)
  • [25] PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance
    Han, Eun Kyung
    Woo, Ji Won
    Suh, Koung Jin
    Kim, Se Hyun
    Kim, Jee Hyun
    Park, So Yeon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 557 - 566
  • [26] PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
    Jing Ma
    Jianhui Li
    Meirui Qian
    Weili Han
    Miaomiao Tian
    Zengshan Li
    Zhe Wang
    Shuixiang He
    Kaichun Wu
    Diagnostic Pathology, 13
  • [27] Immunohistochemical Assessment of the Diagnostic Utility of PD-L1 (Clone SP142) for Methotrexate-Associated Lymphoproliferative Disorders With an Emphasis of Neoplastic PD-L1 (Clone SP142)-Positive Classic Hodgkin Lymphoma Type
    Kohno, Kei
    Suzuki, Yuka
    Elsayed, Ahmed A.
    Sakakibara, Ayako
    Takahara, Taishi
    Satou, Akira
    Kato, Seiichi
    Nakamura, Shigeo
    Asano, Naoko
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (05) : 571 - 582
  • [28] Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer
    Woo, Ji Won
    Han, Eun Kyung
    Suh, Koung Jin
    Kim, Se Hyun
    Kim, Jee Hyun
    Park, So Yeon
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (02) : 301 - 311
  • [29] Correlation of PD-L1 SP142 Immune Cell Positivity with Tumor Mutational Burden and Microsatellite Instability in Triple Negative Breast Cancer
    Brown, C. A.
    Li, X.
    Huang, R. S.
    Severson, E.
    Edgerly, C.
    Duncan, D.
    Hemmerich, A.
    Smith, C.
    Thompson, B.
    Xiao, J.
    Virgilio, J.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Britt, N.
    Elvin, J.
    Owens, C.
    Miller, V. A.
    Alexander, B.
    Ross, J. S.
    Ramkissoon, S. H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1207 - 1208
  • [30] SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer
    Baek, Seung Ho
    Kim, Jee Hung
    Bae, Soong June
    Ji, Jung Hwan
    Lee, Yangkyu
    Jeong, Joon
    Cha, Yoon Jin
    Ahn, Sung Gwe
    CANCERS, 2022, 14 (13)
12345